Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03477539
Title Daratumumab in Treating Transplant-Eligible Participants With Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic

multiple myeloma


Daratumumab + Lenalidomide


Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
*Shaded cells indicate that there was no data available from for the field